EN
ENGN
enGene Therapeutics Inc.
1.53
+0.00%
2026-10-30
Last 90d 1 insider buy worth $10.1K
52-week range
1.40
12.25
1-month-22.7%
3-month-13.6%
1-year-79.1%
3-year-87.3%
vs 50-day-14.9%
vs 200-day-65.0%
Volatility117%
Beta2.11
$ vol/day$1M
ATH47.17
From ATH-96.8%
Next report2026-12-22
Nothing written about ENGN yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 1mo | buy | 1 | $10,051 | 1.94 | |
| 2.0y | buy | 1 | $4,999,993 | 8.79 | |
| 2.0y | buy | 1 | $3,013,458 | 9.25 | |
| 2.1y | buy | 1 | $57,000 | 6.61 | |
| 2.5y | sell | 1 | $787,981 | 15.00 |
Next report 2026-12-22 (Tuesday, before open, in 52 days) · EPS estimate -0.46. It has finished the next session higher 55% of the time, average move 5.8%.
Day-after move, last 11 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | miss | -0.43 | -0.47 | -9.9% | +0.0% | +5.5% | +3.8% |
| 2026-06-15 | beat | -0.47 | -0.43 | +8.6% | +8.0% | +9.3% | +5.6% |
| 2026-03-09 | beat | -0.57 | -0.44 | +23.3% | -7.1% | -18.8% | -16.7% |
| 2025-12-22 | miss | -0.58 | -0.73 | -26.2% | +0.0% | +5.1% | +3.0% |
| 2025-09-11 | miss | -0.51 | -0.57 | -12.1% | +0.0% | -5.8% | +12.5% |
| 2025-06-12 | miss | -0.48 | -0.51 | -6.2% | +4.3% | +0.9% | -2.2% |
| 2025-03-10 | miss | -0.37 | -0.48 | -29.1% | +2.1% | -1.7% | -1.7% |
| 2024-12-19 | beat | -0.36 | -0.34 | +6.1% | +9.7% | -2.2% | +13.3% |
| 2024-09-10 | beat | -0.35 | -0.32 | +8.1% | -1.2% | +3.1% | +11.8% |
| 2024-06-14 | miss | -0.27 | -0.38 | -41.4% | +5.7% | -10.0% | -18.7% |
| 2024-03-11 | beat | -0.47 | -0.46 | +2.1% | -0.8% | +1.6% | +8.9% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.8%
Next 1 week
+5.1%
Next 1 month
+5.3%
Mean reversion
Neutral — RSI(2) at 23
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.31%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 2.11 +5.3% · Seasonal tilt (3y) -0.0%
$1M/day volume
117% volatility
-79% 1-year
52-week range · 1% of the way up · -88% from the high
$1.40$12.25
Not investment advice.
Continue with Google